Wolverine Trading
ALIM

Wolverine Trading’s Alimera Sciences ALIM Stock Holding History

Wolverine Trading’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,188
Closed -$25.5K – 5133
2017
Q1 		$25K Sell
1,188
-714
-38% -$13.8K ﹤0.01% 4084
2016
Q4 		$31K Sell
1,902
-492
-21% -$9.01K ﹤0.01% 4277
2016
Q3 		$54K Buy
+2,394
New +$55.1K ﹤0.01% 4385

Other funds holding ALIM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wolverine Trading's ALIM Position: Q2 2017 in Review

Wolverine Trading sold out of Alimera Sciences (ALIM) in Q2 2017, closing a stake of 1,188 shares — an estimated $25.5K sold.

Wolverine Trading first reported a position in ALIM in Q3 2016 and held it in 3 quarters. The position peaked at $54K in Q3 2016. 38 funds tracked by Wall St. Rank hold ALIM as of Q2 2017.

  • Wolverine Trading reported no remaining Alimera Sciences position as of Q2 2017 after selling out during the quarter.
  • Wolverine Trading sold 1,188 Alimera Sciences shares in Q2 2017, an estimated $25.5K.
  • Wolverine Trading first reported a position in Alimera Sciences in Q3 2016 and held it in 3 quarters.
  • Wolverine Trading's Alimera Sciences position peaked at $54K in Q3 2016.
  • 38 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2017.

Based on Wolverine Trading's 13F filing for Q2 2017, filed 14 Aug 2017.